Individual risk factors for venous thromboembolism (VTE) in cancer patients treated with targeted therapies (TT)

被引：0
|
作者：
Soini, B.
Caffo, O.
Ferro, A.
Ambrosini, G.
Murgia, V.
Valduga, F.
Caldara, A.
Eccher, C.
Tumulo, S.
Galligioni, E.
机构：
[1] Santa Chiara Hosp, Trento, Italy
[2] Fdn Bruno Kessler, Trento, Italy
[3] S Maria Angeli Hosp, Pordenone, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20549
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Risk factors for recurrence in patients with cancer-associated venous thromboembolism: results from the Hokusai-VTE cancer study
    Bosch, F. T. M.
    Wang, T. -F.
    Di Nisio, M.
    Segers, A.
    Connors, J. M.
    Garcia, D.
    Mulder, F. I.
    Weitz, J.
    Buller, H. R.
    Carrier, M.
    Verhamme, P.
    Grosso, M.
    Raskob, G.
    van Es, N.
    THROMBOSIS RESEARCH, 2021, 200 : S14 - S15
  • [42] New epidemiological risk factors for venous thromboembolism (VTE) after menopause
    Grandone, E
    Margaglione, M
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) : 70 - 70
  • [43] Risk factors for venous thromboembolism (VTE) during chemotherapy in patients with germ cell tumors (GCT).
    Griswold, Cassia R.
    Bailey, Erin B.
    Mauser, Jessica Campaign
    Boucher, Kenneth M.
    Agarwal, Neeraj
    Gupta, Sumati
    Maughan, Benjamin Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [44] Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinoma
    van der Boom, Trynke
    Hesselink, Esther N. Klein
    Kooistra, Hilde A. M.
    Meijer, Karina
    van der Horst-Schrivers, Anouk N. A.
    Lefrandt, Joop D.
    Links, Thera P.
    ENDOCRINE-RELATED CANCER, 2017, 24 (06) : 267 - 273
  • [45] Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: a Real-world Analysis of VTE Risk and the Impact of VTE on Healthcare Expenditure
    Lyman, G. H.
    Wang, Y.
    Wang, H.
    Cohen, A. T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S222 - S222
  • [46] Predicting the risk of recurrent venous thromboembolism (VTE)
    Michael B. Streiff
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 353 - 366
  • [47] Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies
    Santoni, Matteo
    Guerra, Federico
    Conti, Alessandro
    Lucarelli, Alessandra
    Rinaldi, Silvia
    Belvederesi, Laura
    Capucci, Alessandro
    Berardi, Rossana
    CANCER TREATMENT REVIEWS, 2017, 59 : 123 - 131
  • [48] Predicting the risk of recurrent venous thromboembolism (VTE)
    Streiff, Michael B.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (03) : 353 - 366
  • [49] Risk factors for post-discharge bleeding in US medically ill patients at risk of Venous Thromboembolism (VTE)
    Mahan, C.
    Klaskala, W.
    Fisher, M.
    Fu, A-C
    Fields, L. E.
    Mills, R.
    Stephenson, J. J.
    Wasser, T.
    Singer, J.
    Spyropoulos, A. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 410 - 410
  • [50] Impact of Venous Thromboembolism (VTE) Prophylaxis and Risk Stratification with the Caprini Model in Hospitalized Patients with Cancer
    Ruch, Joshua M.
    Hu, Hsou M.
    Bahl, Vinita
    Sood, Suman L.
    BLOOD, 2012, 120 (21)
12345